Antibodies internalization mechanisms by dendritic cells and their role in therapeutic antibody immunogenicity
- PMID: 37985174
- DOI: 10.1002/eji.202250340
Antibodies internalization mechanisms by dendritic cells and their role in therapeutic antibody immunogenicity
Abstract
Internalization and processing by antigen-presenting cells such as dendritic cells (DCs) are critical steps for initiating a T-cell response to therapeutic antibodies. Consequences are the production of neutralizing antidrug antibodies altering the clinical response, the presence of immune complexes, and, in some rare cases, hypersensitivity reactions. In recent years, significant progress has been made in the knowledge of cellular uptake mechanisms of antibodies in DCs. The uptake of antibodies could be directly related to their immunogenicity by regulating the quantity of materials entering the DCs in relation to antibody structure. Here, we summarize the latest insights into cellular uptake mechanisms and pathways in DCs. We highlight the approaches to study endocytosis, the impact of endocytosis routes on T-cell response, and discuss the link between how DCs internalize therapeutic antibodies and the potential mechanisms that could give rise to immunogenicity. Understanding these processes could help in developing assays to evaluate the immunogenicity potential of biotherapeutics.
Keywords: Dendritic cells; Immunogenicity; Internalization; Therapeutic Antibodies.
© 2023 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.
References
-
- Dingman, R. and Balu-Iyer, S. V., Immunogenicity of protein pharmaceuticals. J. Pharm. Sci. 2019. 108: 1637-1654.
-
- Vultaggio, A., Petroni, G., Pratesi, S., Nencini, F., Cammelli, D., Milla, M., Prignano, F. et al., Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions. Clin. Exp. Immunol. 2016. 186: 364-372.
-
- Moussa, E. M., Panchal, J. P., Moorthy, B. S., Blum, J. S., Joubert, M. K., Narhi, L. O., Topp, E. M. et al., Immunogenicity of therapeutic protein aggregates. J. Pharm. Sci. 2016. 105: 417-430.
-
- Jawa, V., Terry, F., Gokemeijer, J., Mitra-Kaushik, S., Roberts, B. J., Tourdot, S. and De Groot, A. S., T-cell dependent immunogenicity of protein therapeutics pre-clinical assessment and mitigation-updated consensus and review 2020. Front. Immunol. 2020. 11: 1301.
-
- Tai, Y., Wang, Q., Korner, H., Zhang, L. and Wei, W., Molecular mechanisms of T cells activation by dendritic cells in autoimmune diseases. Front. Pharmacol. 2018. 9: 642.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
